Professor, Medicine, University of Texas Medical School, San Antonio
Oncology
Dr. Tyler J. Curiel, MD
|
|
Give Review
Tyler Curiel works in the field of Oncology. He went to Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He over the years received 1 awards: "Regional Top Doctor". Doctor Tyler J. Curiel, MD is also published. He has 100 publications published. The lastest publication: "Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.' Doctor Tyler J. Curiel, MD accepts Medicare.
Publications
- Prevention of carcinogen and inflammation-induced dermal Cancer by oral rapamycin includes reducing genetic damage.
- Immunotherapy for ovarian Cancer.
- Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell-Dependent Mechanism.
- Sequential Intravesical Mitomycin plus Bacillus Calmette-Guérin for Non-Muscle Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial.
- Combined autophagy and HDAC inhibition: A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic Analysis of hydroxychloroquine in combination with the HDA...
- Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis.
- eRapa Restores A Normal Life Span in a FAP Mouse Model.
- Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice.
- TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-?-mediated nitric oxide production.
- Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
- Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice.
- Immunotherapy: A useful strategy to help combat multidrug resistance.
- Aging-associated B7-DC(+) B cells enhance anti-tumor immunity via Th1 and Th17 induction.
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
- Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
- Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis.
- Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast Cancer.
- B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.
- Antigen-specific immunity and cross-priming by epithelial Ovarian carcinoma-induced CD11b(+)Gr-1(+) cells.
- CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
- Altering regulatory T cell function in Cancer immunotherapy: a novel means to boost the efficacy of Cancer vaccines.
- Regulatory T cells: a new frontier in Cancer immunotherapy.
- Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.
- IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.
- Tregs and rethinking Cancer immunotherapy.
- Regulatory T-cell development: is Foxp3 the decider?
- Antiestrogenic glyceollins suppress human breast and Ovarian carcinoma tumorigenesis.
- Murder or mercy? Hurricane Katrina and the need for disaster training.
- p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator ...
- After the storm--health care infrastructure in post-Katrina New Orleans.
- NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.
- High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.
- CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian Cancers.
- Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.
- Specific recruitment of regulatory T cells in Ovarian carcinoma fosters immune privilege and predicts reduced survival.
- Dendritic cell subsets differentially regulate angiogenesis in human ovarian Cancer.
- Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.
- Peptides identified through phage display direct immunogenic antigen to dendritic cells.
- Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection.
- Immunologic principles and immunotherapeutic approaches in ovarian Cancer.
- Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
- Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis.
- Tumor immunotherapy: inching toward the finish line.
- Optimization of immunotherapy in elderly Cancer patients.
- Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
- Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
- Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection.
- Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.
- Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin.
- Stimulation of human T lymphocytes obtained from Toxoplasma gondii-seronegative persons by proteins derived from T. gondii.
- Gene therapy strategies for AIDS-related malignancies.
- Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis.
- Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.
- Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.
- Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model ...
- Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection.
- Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
- Leukocyte subpopulations in cerebrospinal fluid of normal rabbits.
- Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate.
- Cross-reactivity of human Toxoplasma-specific T cells: implications for development of a potential immunotherapeutic or vaccine.
- Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.
- CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.
- CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.
- HIV-specific cellular and humoral immune responses in primary HIV infection.
- Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells.
- HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937.
- Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphoc...
- Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
- Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene.
- Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells.
- HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells.
- Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung Cancer during pregnancy.
- Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
- Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.
- Transplantation of enriched CD34-positive autologous marrow into breast Cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood p...
- A 113-amino acid fragment of CD4 produced in Escherichia coli blocks human immunodeficiency virus-induced cell fusion.
- Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B ...
- Pyrogenic reactions in patients undergoing cardiac catheterization associated with contaminated glass medicine cups.
- Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung Cancer.
- Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of ...
- Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells.
- Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
- B7-H4 expression identifies a novel suppressive macrophage population in human Ovarian carcinoma.
- Inhibitory B7 family members in human Ovarian carcinoma.
- Current status of therapy for chronic myeloid leukemia: a review of drug development.
- Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human Ovarian carcinoma.
- Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
- Neuronal stem cells biology and plasticity.
- Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii.
- Cancer gene therapy and immunotherapy.
- Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung Cancer: a dose finding study.
- Regulatory T cells in ovarian Cancer: biology and therapeutic potential.
- Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies.
- Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast Cancer cells through survivin suppression.
- Regulatory T cells and treatment of Cancer.
- Trends in immunoconjugate and ligand-receptor based targeting development for Cancer therapy.
- Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens.
- Immune therapy for ovarian Cancer: promise and pitfalls.
- A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo.
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Cervical Cancer
- Colorectal Cancer
- View All
Doctors Specialties
- Infectious Disease Medicine
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Colorado -
Massachusetts General Hospital -
Yale New Haven Children's Center -
Duke University School of Medicine
Hospital
-
South Texas Veterans Health Care System -
University Health System
Drug Facts
| NPI NUMBER | 1184799256 | |
| NPPES Provider LastName | CURIEL | |
| NPPES Provider FirstName | TYLER | |
| NPPES Provider ZIPCode | 782294427 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184799256 |
| Last Name Of The Provider | CURIEL |
| First Name Of The Provider | TYLER |
| View All |
Similar Doctors
|
|
Dr. Lindsay L. Peterson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven P. Kalter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sridhar Beeram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irene Kazhdan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand B. Karnad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edsel L. Hesita, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David P. Dooley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Bartels, MD |
|
|
Dr. Virginia G. Kaklamani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil Ahuja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles F. Lemaistre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriela E. Brzankalski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron D. Owens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane C. Homeyer, MD |
|
|
Dr. George Thompson III, MD |
|
|
Dr. Allison M. Garner, MD
This Doctor is OpenDoctor Recommended.
|